What was new, interesting and frequently cited in 2009?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 260, Issue 2, 2010, Pages 87-89

  Falkai, P ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; LITHIUM; NEUROLEPTIC AGENT; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALZHEIMER DISEASE; DEMENTIA; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; MAJOR DEPRESSION; MILD COGNITIVE IMPAIRMENT; MONOTHERAPY; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SCHIZOPHRENIA; STIGMA; TREATMENT RESPONSE;

BIBLIOMETRICS; HISTORY, 21ST CENTURY; HUMANS; MENTAL DISORDERS; PUBLISHING;

EID: 77950859127     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-010-0103-4     Document Type: Editorial

References (11)

1. M Bauer P Tharmanathan HP Volz HJ Moeller N Freemantle 2009 The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis Eur Arch Psychiatry Clin Neurosci 259 172 185 10.1007/s00406-008-0849-0 19165525
2. G Juckel I Uhl F Padberg M Brüne C Winter 2009 Psychosurgery and deep brain stimulation as ultima ratio treatment for refractory depression Eur Arch Psychiatry Clin Neurosci 259 1 7 10.1007/s00406-008-0826-7 19137233
3. J Kuhn W Gaebel J Klosterkoetter C Woopen 2009 Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment Eur Arch Psychiatry Clin Neurosci 259 Suppl 2 S135 S141 10.1007/s00406-009-0055-8 19876671
4. G Schomerus H Matschinger MC Angermeyer 2009 The stigma of psychiatric treatment and help-seeking intentions for depression Eur Arch Psychiatry Clin Neurosci 259 298 306 10.1007/s00406-009-0870-y 19224105
5. CT Mendes FB Mury E de Sá Moreira FL Lopes Alberto OV Forlenza E Dias-Neto WF Gattaz 2009 Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease Eur Arch Psychiatry Clin Neurosci 259 16 22 10.1007/s00406-008-0828-5 18932008
6. BS Diniz JA Pinto Jr ML Gonzaga FM Guimarães WF Gattaz OV Forlenza 2009 To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease Eur Arch Psychiatry Clin Neurosci 259 248 256 10.1007/s00406-008-0864-1 19224111
7. CU Correll AM Frederickson V Figen EJ Ginn-Scott RA Pantaleon Moya JM Kane P Manu 2009 The QTc interval and its dispersion in patients receiving two atypical antipsychotics Eur Arch Psychiatry Clin Neurosci 259 23 27 10.1007/s00406-008-0829-4 18574608
8. T Kircher R Thienel M Wagner U Habel T Kellermann I Frommann S Schwab W Wölwer M von Wilmsdorf DF Braus A Schmitt A Rapp T Stöcker NJ Shah FA Henn H Sauer W Gaebel W Maier F Schneider 2009 Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas Eur Arch Psychiatry Clin Neurosci 259 72 79 10.1007/s00406-008-0837-4 18806920
9. T Kishi T Kitajima M Ikeda Y Yamanouchi Y Kinoshita K Kawashima T Okochi T Okumura T Tsunoka T Inada N Ozaki N Iwata 2009 Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population Eur Arch Psychiatry Clin Neurosci 259 293 297 10.1007/s00406-009-0869-4 19224106
10. D Martins-de-Souza WF Gattaz A Schmitt C Rewerts G Maccarrone E Dias-Neto CW Turck 2009 Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia Eur Arch Psychiatry Clin Neurosci 259 151 163 10.1007/s00406-008-0847-2 19165527
11. B Lutz 2009 From molecular neurodevelopment to psychiatry: new insights in mechanisms underlying cannabis-induced psychosis and schizophrenia Eur Arch Psychiatry Clin Neurosci 259 369 370 10.1007/s00406-009-0029-x 19572159